TW EN

scroll

Go Top

Investigational New Drug (IND) Application Process

Applied INDs (by Scale)(Select chart for the year detail)

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

Applied INDs (by Scale)

2019

TW Single Center

40

TW Multiple Center

18

Multi-Regional Multi-Center

244

Total

302 Case

Update:2020/03/06Source:TFDA

Applied INDs (by Phase)(Select chart for the year detail)

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

Applied INDs (by Phase)

2019

Phase I

61

Phase II

85

Phase III

132

Phase IV/Others

24

Total

302 Case

Update:2020/03/06Source:TFDA

Investigational New Drug (IND) Application Process(Select chart for the year detail)

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

Multiregional clinical trial (MRCT)

2019

MRCT/Total IND application per year

81%

Number of IND application

302

Number of MRCT application

244

Update:2020/03/06Source:TFDA

The Number of IND Approval by Therapeutic Area(Select chart for the corresponding detail)

Neoplasms

40%

Other

19%

Infectious and Parasitic Diseases

8%

Diseases of the Musculoskeletal System and Connective Tissue

5%

Endocrinology, Nutritional, and Metabolism, and Immunity Disorders

5%

Diseases of the Nervous System and Sense Organs

6%

Diseases of the Skin and Subcutaneous Tissue

6%

Diseases of the Digestive System

4%

Diseases of the Circulatory System

4%

Diseases of the Respiratory System

3%

2016-2020

Update:2020/12/31 Source:TFDA